The implantable pacemaker market size in North America, particularly in the United States and Canada, is expected to witness significant growth due to the increasing prevalence of cardiovascular diseases and a growing geriatric population. The availability of advanced healthcare infrastructure and high healthcare expenditure in these countries are also contributing factors to the market growth.
Asia Pacific:
In China, Japan, and South Korea, the implantable pacemaker market is projected to show substantial growth driven by the rising awareness about cardiac diseases and the presence of key market players offering technologically advanced pacemaker devices. The increasing healthcare expenditure and continuous efforts to improve healthcare infrastructure are also expected to fuel market growth in these countries.
Europe:
The United Kingdom, Germany, and France are expected to be significant contributors to the implantable pacemaker market in Europe. The presence of well-established healthcare systems, favorable reimbursement policies, and increasing adoption of advanced medical technologies are expected to drive market growth. Additionally, the rising geriatric population in these countries is likely to increase the demand for implantable pacemakers.